S&P 500

5.475,09

0,27%

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Impax Laboratories (MM) (IPXLE)
Impax Laboratories (MM) (IPXLE) Notícias

IPXLE

Impax labs (IPXLE)

Impax Laboratories (MM)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:IPXLE

1

Data	Hora	Fonte	Título	Código	Companhia
19/01/2017	19:27	Dow Jones News	Rival to EpiPen Allergy Treatment to Return to Market--Update	NASDAQ:IPXLE	Impax Laboratories (MM)
19/01/2017	18:17	Dow Jones News	Rival to EpiPen Allergy Treatment to Return to Market	NASDAQ:IPXLE	Impax Laboratories (MM)
12/01/2017	20:03	Dow Jones News	Cigna Drops Coverage of Mylan's EpiPen for Cheaper Generic -- Update	NASDAQ:IPXLE	Impax Laboratories (MM)
03/11/2016	18:08	Dow Jones News	DOJ Looking Into Possible Price Collusion in Generic Drug Sector -Bloomberg	NASDAQ:IPXLE	Impax Laboratories (MM)
27/07/2016	20:41	Dow Jones News	Correction to Teva, Allergan Article	NASDAQ:IPXLE	Impax Laboratories (MM)
27/07/2016	17:00	Dow Jones News	Teva, Allergan Get FTC Approval for Generics Purchase	NASDAQ:IPXLE	Impax Laboratories (MM)
12/07/2016	20:20	Dow Jones News	Teva Raises Guidance	NASDAQ:IPXLE	Impax Laboratories (MM)
22/06/2016	04:07	Dow Jones News	Business Watch -- WSJ	NASDAQ:IPXLE	Impax Laboratories (MM)
21/06/2016	10:30	Dow Jones News	Teva and Allergan Sell Generic Drugs to Impax In Latest Divestiture	NASDAQ:IPXLE	Impax Laboratories (MM)
31/03/2016	12:50	Dow Jones News	FTC Accuses Endo of Paying Off Generic Drugmakers	NASDAQ:IPXLE	Impax Laboratories (MM)
23/09/2015	00:50	Dow Jones News	Turing to Cut Price of Drug Daraprim After Outcry	NASDAQ:IPXLE	Impax Laboratories (MM)
05/08/2005	05:00	Business Wire	IMPAX Receives Notice of Delisting from Nasdaq	NASDAQ:IPXLE	Impax Laboratories (MM)
03/08/2005	05:00	Business Wire	IMPAX Provides Further Update of Progress in Filing 10-K and 10-Q and Estimates of Results	NASDAQ:IPXLE	Impax Laboratories (MM)
27/06/2005	08:00	Business Wire	IMPAX Laboratories, Inc. Agrees to Sell $75 Million of 3.5% Senior Subordinated Convertible Debentures Due 2012; Proceeds to be	NASDAQ:IPXLE	Impax Laboratories (MM)
20/06/2005	09:01	Business Wire	IMPAX to Increase Existing Credit Facility	NASDAQ:IPXLE	Impax Laboratories (MM)
04/05/2005	10:03	Business Wire	IMPAX Provides Updates on Progress to File 10-K and Related Matters	NASDAQ:IPXLE	Impax Laboratories (MM)
02/05/2005	12:01	Business Wire	CORRECTING and REPLACING IMPAX Receives FDA Approval for Generic Version of Rimadyl, a Veterinary Product; Fourth Approval in 20	NASDAQ:IPXLE	Impax Laboratories (MM)
02/05/2005	10:24	Business Wire	IMPAX Receives FDA Approval for Generic Version of Rimadyl, a Veterinary Product; Fourth Approval in 2005	NASDAQ:IPXLE	Impax Laboratories (MM)